BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36173715)

  • 1. Clinical characteristics of oral chronic graft-versus-host disease according to the 2014 National Institutes of Health (USA) consensus criteria.
    Pengpis N; Prueksrisakul T; Chanswangphuwana C
    Med Oral Patol Oral Cir Bucal; 2023 Mar; 28(2):e167-e173. PubMed ID: 36173715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic response of oral chronic graft-versus-host disease to topical corticosteroids according to the 2014 National Institutes of Health (USA) consensus criteria.
    Siripornkitti W; Pengpis N; Chanswangphuwana C; Prueksrisakul T
    Med Oral Patol Oral Cir Bucal; 2024 Mar; 29(2):e219-e226. PubMed ID: 37823294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral disease profiles in chronic graft versus host disease.
    Bassim CW; Fassil H; Mays JW; Edwards D; Baird K; Steinberg SM; Cowen EW; Naik H; Datiles M; Stratton P; Gress RE; Pavletic SZ
    J Dent Res; 2015 Apr; 94(4):547-54. PubMed ID: 25740857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral involvement of chronic graft-versus-host disease in hematopoietic stem cell transplant recipients.
    Noce CW; Gomes A; Copello A; Barbosa RD; Sant'anna S; Moreira MC; Correa ME; Maiolino A; Torres SR
    Gen Dent; 2011; 59(6):458-62; quiz 463-4. PubMed ID: 22313917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The oral manifestations of chronic graft-versus-host disease (cGVHD) in paediatric allogeneic bone marrow transplant recipients.
    Nicolatou-Galitis O; Kitra V; Van Vliet-Constantinidou C; Peristeri J; Goussetis E; Petropoulos D; Grafakos S
    J Oral Pathol Med; 2001 Mar; 30(3):148-53. PubMed ID: 11271629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral chronic graft-versus-host disease scoring using the NIH consensus criteria.
    Treister NS; Stevenson K; Kim H; Woo SB; Soiffer R; Cutler C
    Biol Blood Marrow Transplant; 2010 Jan; 16(1):108-14. PubMed ID: 19772943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral symptom intensity, health-related quality of life, and correlative salivary cytokines in adult survivors of hematopoietic stem cell transplantation with oral chronic graft-versus-host disease.
    Fall-Dickson JM; Mitchell SA; Marden S; Ramsay ES; Guadagnini JP; Wu T; St John L; Pavletic SZ;
    Biol Blood Marrow Transplant; 2010 Jul; 16(7):948-956. PubMed ID: 20139026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the National Institutes of Health (NIH) scale for oral chronic graft-versus-host disease (cGVHD).
    Elad S; Zeevi I; Or R; Resnick IB; Dray L; Shapira MY
    Biol Blood Marrow Transplant; 2010 Jan; 16(1):62-9. PubMed ID: 19733252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteria.
    Cuvelier GDE; Nemecek ER; Wahlstrom JT; Kitko CL; Lewis VA; Schechter T; Jacobsohn DA; Harris AC; Pulsipher MA; Bittencourt H; Choi SW; Caywood EH; Kasow KA; Bhatia M; Oshrine BR; Flower A; Chaudhury S; Coulter D; Chewning JH; Joyce M; Savaşan S; Pawlowska AB; Megason GC; Mitchell D; Cheerva AC; Lawitschka A; West LJ; Pan B; Al Hamarneh YN; Halevy A; Schultz KR
    Blood; 2019 Jul; 134(3):304-316. PubMed ID: 31043425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of National Institutes of Health global scoring system for chronic graft-versus-host disease (GVHD) according to overall and GVHD-specific survival.
    Moon JH; Sohn SK; Lambie A; Ellis L; Hamad N; Uhm J; Gupta V; Lipton JH; Messner HA; Kuruvilla J; Kim D
    Biol Blood Marrow Transplant; 2014 Apr; 20(4):556-63. PubMed ID: 24447907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of subcategory and severity of chronic graft-versus-host disease evaluated by National Institutes of Health consensus criteria.
    Sato T; Ichinohe T; Kanda J; Yamashita K; Kondo T; Ishikawa T; Uchiyama T; Takaori-Kondo A
    Int J Hematol; 2011 Apr; 93(4):532-541. PubMed ID: 21465116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the NIH consensus criteria in cellular and soluble biomarker research in chronic graft-versus-host disease: A systematic review.
    Milosevic E; Babic A; Iovino L; Markovic M; Grce M; Greinix H
    Front Immunol; 2022; 13():1033263. PubMed ID: 36389657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral health-related quality of life of patients with oral chronic graft-versus-host disease.
    Stolze J; Boor M; Hazenberg MD; Brand HS; Raber-Durlacher JE; Laheij AMGA
    Support Care Cancer; 2021 Nov; 29(11):6353-6360. PubMed ID: 33884507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superficial mucoceles in chronic graft-versus-host disease: a case report and review of the literature.
    Balasubramaniam R; Alawi F; DeRossi S
    Gen Dent; 2009; 57(1):82-8. PubMed ID: 19146147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National Institutes of Health chronic graft-versus-host disease staging in severely affected patients: organ and global scoring correlate with established indicators of disease severity and prognosis.
    Baird K; Steinberg SM; Grkovic L; Pulanic D; Cowen EW; Mitchell SA; Williams KM; Datiles MB; Bishop R; Bassim CW; Mays JW; Edwards D; Cole K; Avila DN; Taylor T; Urban A; Joe GO; Comis LE; Berger A; Stratton P; Zhang D; Shelhamer JH; Gea-Banacloche JC; Sportes C; Fowler DH; Gress RE; Pavletic SZ
    Biol Blood Marrow Transplant; 2013 Apr; 19(4):632-9. PubMed ID: 23340040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and Outcome of Atypical Manifestations of Chronic Graft-versus-Host Disease: Results From a Retrospective Single-Center Analysis.
    Doering J; Perl M; Weber D; Banas B; Schulz C; Hamer OW; Angstwurm K; Holler E; Herr W; Edinger M; Wolff D; Fante MA
    Transplant Cell Ther; 2023 Dec; 29(12):772.e1-772.e10. PubMed ID: 37777112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chronic graft-versus-host-disease involving the oral mucosa: clinical presentation and treatment].
    Elad S; Levitt M; M Y S
    Refuat Hapeh Vehashinayim (1993); 2008 Nov; 25(4):19-27, 72. PubMed ID: 19263864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral chronic graft-vs.-host disease characterization using the NIH scale.
    Fassil H; Bassim CW; Mays J; Edwards D; Baird K; Steinberg SM; Williams KM; Cowen EW; Mitchell SA; Hakim FT; Taylor T; Avila D; Zhang D; Grkovic L; Datiles M; Gress RE; Pavletic SZ
    J Dent Res; 2012 Jul; 91(7 Suppl):45S-51S. PubMed ID: 22699667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral involvement in chronic graft versus host disease: a prospective study of 19 Brazilian patients.
    Pereira CM; de Almeida OP; Correa ME; Souza CA; Barjas-Castro ML
    Gen Dent; 2007; 55(1):48-51. PubMed ID: 17333967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extensive dental caries in patients with oral chronic graft-versus-host disease.
    Castellarin P; Stevenson K; Biasotto M; Yuan A; Woo SB; Treister NS
    Biol Blood Marrow Transplant; 2012 Oct; 18(10):1573-9. PubMed ID: 22516054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.